Stroke Trial, Recruiting NCT05232240 Sponsor: Xuanwu Hospital, Beijing Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05232240
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with an ischemic stroke (a stroke caused by a blocked blood vessel) or a transient ischemic attack (TIA, sometimes called a "mini-stroke"), confirmed by a CT or MRI brain scan.
  • People whose stroke or TIA symptoms began less than 90 days ago.
  • People whose blood pressure, measured between 5 and 90 days after the stroke or TIA and without any blood pressure-lowering medication, reads below 140/90 mmHg (measured correctly after resting, emptying the bladder, and avoiding caffeine, exercise, or smoking for at least 30 minutes, with at least two readings taken on at least two separate occasions).
  • People who agree to take part in the study.

Who may not be able to join:

  • People who have a confirmed diagnosis of high blood pressure (hypertension).
  • People who are currently taking any medication to lower their blood pressure.
  • People whose neurological condition (brain or nerve function) is getting worse.
  • People with a stroke severity score of more than 5 points on the standard NIH Stroke Scale (a clinical measure of stroke impact — confirm with trial site).
  • People who have had bleeding inside the brain (intracranial hemorrhage).
  • People with a condition that affects the body's automatic nervous system functions, such as heart rate and blood pressure control (autonomic failure).
  • People with a serious cancer, poor organ function, or a blood disease where life expectancy is estimated to be less than 3 years.
  • People who are unable to wear a blood pressure monitor for 24 hours or who were not able to complete this monitoring at the start of the study.
  • People with a diagnosed mental illness.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13501390691

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
14 February 2022
Est. completion
1 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

3-year risk of Major Adverse Cardiovascular Event

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov